Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

JAMA Neurology - United States
doi 10.1001/jamaneurol.2018.2598
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

American Medical Association (AMA)

Related search

Correction To: Identification of Multiple Cancer-Associated Myositis-Specific Autoantibodies in Idiopathic Inflammatory Myopathies: A Large Longitudinal Cohort Study

Arthritis Research & Therapy
2018English

Progress Report on Development of Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Management of the Idiopathic Inflammatory Myopathies

Prescriber
Pharmacology
2019English

Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients

Journal of Rheumatology
RheumatologyAllergyImmunology
2017English

A Clinically and Biologically Based Subclassification of the Idiopathic Inflammatory Myopathies Using Machine Learning

ACR Open Rheumatology
2020English

Idiopathic Inflammatory Myopathies Overlapping With Systemic Diseases

Clinical Neuropathology
MedicineForensic MedicinePathologyNeurology
2018English

Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics

Clinical Reviews in Allergy and Immunology
MedicineAllergyImmunology
2016English

Comments on the “2017 Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups”. Points of Concern

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Drugs in Induction and Treatment of Idiopathic Inflammatory Myopathies

Autoimmunity Highlights
RheumatologyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy